Health ministry launches portal for updates on Covid-19 vaccine development

Health Ministry launched a web portal that will provide all important information on Covid-19, vaccine development, ongoing clinical trials and progress made in this area locally and globally

Covid-19 coronavirus
Press Trust of India New Delhi
3 min read Last Updated : Sep 28 2020 | 8:40 PM IST

The Union Health Ministry on Monday launched a web portal that will provide all important information on Covid-19, vaccine development, ongoing clinical trials and progress made in this area locally and globally.

The 'vaccine web portal' and the 'National Clinical Registry for Covid-19' have been developed by the Indian Council of Medical Research (ICMR) and was launched by Union Health Minister Harsh Vardhan, according to a health ministry statement.

The National Clinical Registry for Covid-19 will collect systematic data on clinical signs and symptoms, laboratory investigations, management protocols, the clinical course of Covid-19, disease spectrum and outcomes of patients.

"The data will serve as an invaluable tool for formulating appropriate patient management strategies, predicting disease severity, patient outcomes etc," the ICMR said in a statement.

The vaccine portal contains all information regarding Indian efforts towards the development of a vaccine against Covid-19.

"Interested people can visit the website on vaccine.icmr.org.in to get the latest information on vaccine development," it said

Vardhan said, "The portal provides useful and important information related to vaccine development, ongoing clinical trials and progress made in this area locally and globally at regular intervals. Today, in the times of coronavirus pandemic, vaccine development is watched very closely. Thus, it becomes important to showcase the status of vaccine development in the country."

On India's fight against Covid-19, the health minister said the continuously rising recovery rate and progressively falling case fatality rate in the country have proven the success of the Covid-19 containment strategy followed by all states and Union Territories.

"From having one laboratory (for Covid-19 testing) to over 1,800 today, we have come a long way in strengthening our capabilities. We have successfully ramped up our testing capacity which has touched 15 lakh daily tests," he said.

He also lauded the healthcare personnel working selflessly to serve the people "even at a time when the resources are limited" due to coronavirus.

Apart from the 'vaccine web portal' and the 'National Clinical Registry for Covid-19', Vardhan also unveiled a timeline depicting the ICMR's historical achievements and inaugurated apex health research body's mobile stroke unit, the statement said.

Vardhan unveiled the timeline of the ICMR depicting the 108-year journey of the body since its inception in 1911 when it was known as Indian Research Fund Association, it said.

According to the statement, the timeline captures the policy and programme interventions by the ICMR and its institutes to control diseases and its pioneering work in the fields of maternal and child health, HIV, cancer and nutrition, among others.

Unveiling the new exhibits, Vardhan said, "The ICMR has always been in the forefront of health research in India and is now leading the country in tackling the unprecedented pandemic through scientific rigour and innovation.

"It has contributed immensely towards the nation's welfare. Through these exhibits, people will take pride in knowing the contributions of ICMR and the country in the area of medical science."

Launching the mobile stroke unit, Vardhan said it is disheartening to see the susceptibility of people to heart disease and hypertension and timely treatment can reduce fatality and prevent people from disability.

"Given the large burden of stroke and absence of stroke care facilities in Assam, this initiative will go a long way in addressing the needs of the people in this area. The mobile unit, through teleconsultation, ensures timely and appropriate treatment to the people," he said.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineHealth Ministry

First Published: Sep 28 2020 | 7:08 PM IST

Next Story